Company profile TCON

TRACON Pharmaceuticals Inc
tracon pharmaceuticals, inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer and wet age-related macular degeneration (amd). its lead clinical stage products include envafolimab (kn035), an investigational pd-l1 single-domain antibody for the treatment of soft tissue sarcoma. the company's clinical stage p...roducts also include de-122, which is in randomized phase iia study for the treatment of wet amd; trc102, which is a small molecule that is in phase ii clinical trial for the treatment of mesothelioma, phase i clinical trial to treat solid tumors, phase i/ii to treat solid tumors and lymphomas, and phase i trial to treat lung cancer; trc253, a small molecule, which is in a phase ii clinical trial for the treatment of metastatic castration-resistant prostate cancer; and tj004309, a cd73 antibody that is in phase i clinical development for the treatment of solid tumors. it has collaboration and license agreements w Show More
Quarter analysis & expected interestLast update: February 07 2024 23:22:27.

After 38 days of this quarter the interest is at 29.0. Based on that we can calculate that during remaining 53 days it will total up to 69.0.
TRACON Pharmaceuticals expected interest is significantly lower compared to same quarter last year (-42.5%) but similar to previous quarter.

YearQ1Q2Q3Q4
201991
219
140.7% QoQ
241
10.0% QoQ
90
-62.7% QoQ
2020 395
334.1% YoY 338.9% QoQ
103
-53.0% YoY -73.9% QoQ
347
44.0% YoY 236.9% QoQ
191
112.2% YoY -45.0% QoQ
2021 118
-70.1% YoY -38.2% QoQ
153
48.5% YoY 29.7% QoQ
129
-62.8% YoY -15.7% QoQ
104
-45.5% YoY -19.4% QoQ
2022 134
13.6% YoY 28.8% QoQ
68
-55.6% YoY -49.3% QoQ
154
19.4% YoY 126.5% QoQ
221
112.5% YoY 43.5% QoQ
2023 120
-10.4% YoY -45.7% QoQ
133
95.6% YoY 10.8% QoQ
147
-4.5% YoY 10.5% QoQ
74
-66.5% YoY -49.7% QoQ
2024 29
-75.8% YoY -60.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and TRACON Pharmaceuticals search interestLast update: February 07 2024 23:22:26.
Correlation coefficient between keyword and revenue is -0.36
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 07 2024 23:22:27.

The average 5 years interest of TRACON Pharmaceuticals was 12.54 per week.
The last year interest of TRACON Pharmaceuticals compared to the last 5 years has changed by -29.43%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -43.81%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for TRACON Pharmaceuticals login to provide analysis

Correlation between past revenue and TRACON Pharmaceuticals login search interest

There is not enough data for TRACON Pharmaceuticals login to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for TRACON Pharmaceuticals login to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for TRACON Pharmaceuticals news to provide analysis

Correlation between past revenue and TRACON Pharmaceuticals news search interest

There is not enough data for TRACON Pharmaceuticals news to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for TRACON Pharmaceuticals news to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 07 2024 23:22:30.

After 38 days of this quarter the interest is at 40.0. Based on that we can calculate that during remaining 53 days it will total up to 96.0.
envafolimab expected interest is significantly lower compared to same quarter last year (-62.8%) but similar to previous quarter.

YearQ1Q2Q3Q4
2019103
70
-32.0% QoQ
67
-4.3% QoQ
68
1.5% QoQ
2020 84
-18.4% YoY 23.5% QoQ
86
22.9% YoY 2.4% QoQ
86
28.4% YoY 0.0% QoQ
53
-22.1% YoY -38.4% QoQ
2021 133
58.3% YoY 150.9% QoQ
119
38.4% YoY -10.5% QoQ
140
62.8% YoY 17.6% QoQ
153
188.7% YoY 9.3% QoQ
2022 0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
103
-26.4% YoY inf% QoQ
58
-62.1% YoY -43.7% QoQ
2023 258
inf% YoY 344.8% QoQ
48
inf% YoY -81.4% QoQ
0
-100.0% YoY -100.0% QoQ
112
93.1% YoY inf% QoQ
2024 40
-84.5% YoY -64.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and envafolimab search interestLast update: February 07 2024 23:22:29.
Correlation coefficient between keyword and revenue is -0.47
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 07 2024 23:22:30.

The average 5 years interest of envafolimab was 6.85 per week.
The last year interest of envafolimab compared to the last 5 years has changed by 3.94%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 20.27%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for YH001 to provide analysis

Correlation between past revenue and YH001 search interest

There is not enough data for YH001 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for YH001 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for TRC102 to provide analysis

Correlation between past revenue and TRC102 search interest

There is not enough data for TRC102 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for TRC102 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for TJ004309 to provide analysis

Correlation between past revenue and TJ004309 search interest

There is not enough data for TJ004309 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for TJ004309 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for TRACON Pharmaceuticals careers to provide analysis

Correlation between past revenue and TRACON Pharmaceuticals careers search interest

There is not enough data for TRACON Pharmaceuticals careers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for TRACON Pharmaceuticals careers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 07 2024 23:22:33.

After 38 days of this quarter the interest is at 43.0. Based on that we can calculate that during remaining 53 days it will total up to 103.0.
TRACON Pharmaceuticals stock expected interest is significantly higher compared to same quarter last year (+49.3%) but lower than previous quarter (-58.8%).

YearQ1Q2Q3Q4
201925
346
1284.0% QoQ
40
-88.4% QoQ
123
207.5% QoQ
2020 131
424.0% YoY 6.5% QoQ
0
-100.0% YoY -100.0% QoQ
318
695.0% YoY inf% QoQ
251
104.1% YoY -21.1% QoQ
2021 79
-39.7% YoY -68.5% QoQ
124
inf% YoY 57.0% QoQ
187
-41.2% YoY 50.8% QoQ
61
-75.7% YoY -67.4% QoQ
2022 57
-27.8% YoY -6.6% QoQ
66
-46.8% YoY 15.8% QoQ
58
-69.0% YoY -12.1% QoQ
32
-47.5% YoY -44.8% QoQ
2023 69
21.1% YoY 115.6% QoQ
71
7.6% YoY 2.9% QoQ
108
86.2% YoY 52.1% QoQ
250
681.2% YoY 131.5% QoQ
2024 43
-37.7% YoY -82.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and TRACON Pharmaceuticals stock search interestLast update: February 07 2024 23:22:33.
Correlation coefficient between keyword and revenue is 0.5
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 07 2024 23:22:34.

The average 5 years interest of TRACON Pharmaceuticals stock was 9.38 per week.
The last year interest of TRACON Pharmaceuticals stock compared to the last 5 years has changed by 5.22%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by -9.62%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for TCON
Earnings date: 2024-02-29 After close
Company name: TRACON Pharmaceuticals Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2024-11-14T20:51:58-05:00

SEC
SC 13G/A Form - [Amend] Statement of Beneficial Ownership by Certain Investors - Tracon Pharmaceuticals, Inc. (0001394319) (Subject)

2024-11-07T16:05:49-05:00

SEC
15-12G Form - Securities registration termination [Section 12(g)] - Tracon Pharmaceuticals, Inc. (0001394319) (Filer)

2024-11-04T00:15:10-05:00

SEC
EFFECT Form - Notice of Effectiveness - Tracon Pharmaceuticals, Inc. (0001394319) (Filer)

2024-11-04T00:15:09-05:00

SEC
EFFECT Form - Notice of Effectiveness - Tracon Pharmaceuticals, Inc. (0001394319) (Filer)

2024-11-04T00:15:08-05:00

SEC
EFFECT Form - Notice of Effectiveness - Tracon Pharmaceuticals, Inc. (0001394319) (Filer)

2024-11-04T00:15:06-05:00

SEC
EFFECT Form - Notice of Effectiveness - Tracon Pharmaceuticals, Inc. (0001394319) (Filer)

2024-11-04T00:15:06-05:00

SEC
EFFECT Form - Notice of Effectiveness - Tracon Pharmaceuticals, Inc. (0001394319) (Filer)

2024-11-04T00:15:05-05:00

SEC
EFFECT Form - Notice of Effectiveness - Tracon Pharmaceuticals, Inc. (0001394319) (Filer)

2024-11-04T00:15:04-05:00

SEC
EFFECT Form - Notice of Effectiveness - Tracon Pharmaceuticals, Inc. (0001394319) (Filer)

2024-11-04T00:15:04-05:00

SEC
EFFECT Form - Notice of Effectiveness - Tracon Pharmaceuticals, Inc. (0001394319) (Filer)

2024-10-31T17:00:02-04:00

SEC
RW Form - Registration Withdrawal Request - Tracon Pharmaceuticals, Inc. (0001394319) (Filer)

2024-10-31T16:45:03-04:00

SEC
POS AM Form - Post-Effective amendments for registration statement - Tracon Pharmaceuticals, Inc. (0001394319) (Filer)

2024-10-31T16:45:03-04:00

SEC
POS AM Form - Post-Effective amendments for registration statement - Tracon Pharmaceuticals, Inc. (0001394319) (Filer)

2024-10-31T16:45:03-04:00

SEC
POS AM Form - Post-Effective amendments for registration statement - Tracon Pharmaceuticals, Inc. (0001394319) (Filer)

2024-10-31T16:45:02-04:00

SEC
POS AM Form - Post-Effective amendments for registration statement - Tracon Pharmaceuticals, Inc. (0001394319) (Filer)